These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26162688)

  • 1. Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.
    Hedrick E; Crose L; Linardic CM; Safe S
    Mol Cancer Ther; 2015 Sep; 14(9):2143-53. PubMed ID: 26162688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.
    Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S
    Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
    Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
    Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
    Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
    Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
    Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
    Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells.
    Tomoyasu C; Kikuchi K; Kaneda D; Yagyu S; Miyachi M; Tsuchiya K; Iehara T; Sakai T; Hosoi H
    Oncol Rep; 2019 Jan; 41(1):643-649. PubMed ID: 30365145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
    Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma.
    Ghayad SE; Rammal G; Sarkis O; Basma H; Ghamloush F; Fahs A; Karam M; Harajli M; Rabeh W; Mouawad JE; Zalzali H; Saab R
    Cancer Biol Ther; 2019; 20(3):272-283. PubMed ID: 30307360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
    Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
    Heinicke U; Fulda S
    Cancer Lett; 2014 Aug; 351(1):50-8. PubMed ID: 24814395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
    Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
    Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma.
    Camero S; Milazzo L; Vulcano F; Ceccarelli F; Pontecorvi P; Pedini F; Rossetti A; Scialis ES; Gerini G; Cece F; Pomella S; Cassandri M; Porrazzo A; Romano E; Festuccia C; Gravina GL; Ceccarelli S; Rota R; Lotti LV; Midulla F; Angeloni A; Marchese C; Marampon F; Megiorni F
    BMC Cancer; 2024 Jul; 24(1):814. PubMed ID: 38977944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent.
    Shen J; Hong Y; Zhao Q; Zhang JL
    Tumour Biol; 2016 Jan; 37(1):1025-33. PubMed ID: 26269112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells.
    Haydn T; Metzger E; Schuele R; Fulda S
    Cell Death Dis; 2017 Jun; 8(6):e2879. PubMed ID: 28617441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines.
    Marampon F; Di Nisio V; Pietrantoni I; Petragnano F; Fasciani I; Scicchitano BM; Ciccarelli C; Gravina GL; Festuccia C; Del Fattore A; Tombolini M; De Felice F; Musio D; Cecconi S; Tini P; Maddalo M; Codenotti S; Fanzani A; Polimeni A; Maggio R; Tombolini V
    Cancer Lett; 2019 Oct; 461():90-101. PubMed ID: 31325529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cells.
    Laszig S; Boedicker C; Weiser T; Knapp S; Fulda S
    Cancer Lett; 2020 Aug; 486():46-57. PubMed ID: 32445837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.
    Enßle JC; Boedicker C; Wanior M; Vogler M; Knapp S; Fulda S
    Cancer Lett; 2018 Aug; 428():160-172. PubMed ID: 29709701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.